Why Pot Stocks Stink

The best-selling drug class in history is about to get better—and a lot bigger. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising. 

Seaport Research’s Jonathan Golub examines quarterly results. Todd Brighton of Franklin Income Investors likes convertibles. And Jack talks breakdancing and actuarial seconds. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and u ...  Show more

Cannabis stocks have been generally up this week, and are even outperforming the S&P 500 - but we're also seeing management shakeups, layoffs and supply chain disruption. Bruce Linton, industry trailblazer and executive chairman at Vireo Health, shares his insights into the secto ...  Show more

After decades of long/short equity investing for hedge funds on the sell side, Mike Regan switched to covering the cannabis space for MJBizDaily. He joins Rena Sherbill to discuss the similarities between the internet bubble and the cannabis market today and what we can glean fro ...  Show more

Cannabis expert Jesse Redmond shares why he's now at LEEF Brands (1:30). Excited about New York's evolution (8:15). How and why it got so bad in the industry (16:00). Are we early or are we wrong? (22:05) Who may survive and get to the finish line (28:35). Intoxicating hemp marke ...  Show more

Macy’s posts a rock-solid 2nd-quarter and raises guidance, so why are shares down? Matt Argersinger analyzes the great recent run Macy’s has had and shares why some investors are jumping ship now. Constellation Brands makes a $4 billion investment in Canopy Growth, one of Canada’ ...  Show more